This announcement is a separate document:
仁和药业：关于全资子公司江西仁和药业有限公司转让江西仁翔药业有限公司51%股权的公告
Renhe Pharmaceutical: Announcement on the transfer of 51% of the shares of Jiangxi Renxiang Pharmaceutical Co., Ltd., a wholly-owned subsidiary, Jiangxi Renhe Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.